Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Macitentan

Catalog No. T2561Cas No. 441798-33-0
Alias ACT-064992

Macitentan (ACT-064992) is an endothelin receptor antagonist utilized in the treatment of pulmonary arterial hypertension (PAH).

Macitentan

Macitentan

Purity: 100%
Catalog No. T2561Alias ACT-064992Cas No. 441798-33-0
Macitentan (ACT-064992) is an endothelin receptor antagonist utilized in the treatment of pulmonary arterial hypertension (PAH).
Pack SizePriceAvailabilityQuantity
10 mg$37In Stock
25 mg$44In Stock
50 mg$51In Stock
100 mg$76In Stock
500 mg$178In Stock
1 mL x 10 mM (in DMSO)$34In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Macitentan"

Select Batch
Purity:100%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Macitentan (ACT-064992) is an endothelin receptor antagonist utilized in the treatment of pulmonary arterial hypertension (PAH).
Targets&IC50
ETB:391 nM, ETA:0.5 nM
In vitro
In DOCA-salt-induced hypertensive rats, Macitentan (10 mg/kg) demonstrated a dose-dependent reduction in mean arterial blood pressure. Similarly, in a model of pulmonary arterial hypertension using monocrotaline-treated rats, oral administration of Macitentan (30 mg/kg/day) dose-dependently prevented the development of pulmonary arterial hypertension and right ventricular hypertrophy. Additionally, in type 2 diabetic db/db mice, oral Macitentan (25 mg/kg/day) reduced mRNA expression while concurrently enhancing NF-κB activation.
In vivo
In primary human lung smooth muscle cells (IC50=1 nM), Macitentan inhibits the increase of intracellular calcium ions induced by ET-1. Additionally, Macitentan suppresses ET-1-induced contraction in isolated rat aortic rings. Furthermore, in isolated rat tracheal rings, Macitentan inhibits contraction induced by S6c.
AliasACT-064992
Chemical Properties
Molecular Weight588.27
FormulaC19H20Br2N6O4S
Cas No.441798-33-0
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
Ethanol: < 1 mg/mL (insoluble or slightly soluble)
H2O: < 1 mg/mL (insoluble or slightly soluble)
DMSO: 93 mg/mL (158.1 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.6999 mL8.4995 mL16.9990 mL84.9950 mL
5 mM0.3400 mL1.6999 mL3.3998 mL16.9990 mL
10 mM0.1700 mL0.8499 mL1.6999 mL8.4995 mL
20 mM0.0850 mL0.4250 mL0.8499 mL4.2497 mL
50 mM0.0340 mL0.1700 mL0.3400 mL1.6999 mL
100 mM0.0170 mL0.0850 mL0.1700 mL0.8499 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Macitentan | purchase Macitentan | Macitentan cost | order Macitentan | Macitentan chemical structure | Macitentan in vivo | Macitentan in vitro | Macitentan formula | Macitentan molecular weight